2[1]Sasco AJ, Lowenfels AB, Pasker-DeJong P. Epidemiology of male breast cancer: A meta-analysis of published case-control studies an discussion of selected aetiological factors. Int J Cancer, 1993, 53:538
3[2]Friedman LS, Gayther SA, Kurosaki T, et al. Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population.Am J Hum Genet, 1997, 60 (2) :313
4[3]Borgen PI, Wong GY, Vlamis V, et al. Current management of male breast cancer. A review of 104 cases. Ann Surg,1992, 215 (5) :451; discussion457
5[4]Vetto J, Jun SY, Paduch D, et al. Stages at presentation,prognostic factors, and outcome of breast cancer in males. Am J Surg, 1999, 177 (5) :379
6[5]Hultborn R, Friberg S, Hultborn KA, et al. Male breast carcinoma. Ⅱ: A study of the total material reported to the Swedish Cancer Registry 1958-1967 with respect to treatment, prognostic factors and survival. Acta Oncol, 1987, 26 (5) :327
7[6]Ribeiro G, Swindell R. Adjuvant tamoxifen for male breast cancer (MBC). Br J Cancer, 1992, 65 (2) :252
8[7]Patel HZ, Buzdar AU, Hortobegyi GN. Role of adjuvant chemotherapy in male breast cancer. Cancer, 1989, 64 (8):1583
9[8]Jaiyesimi IA, Buzdar AU, Sahin AA, et al. Carcinoma of the male breast. Ann Intern Med, 1992, 117 (9) :771
